McKnight Endowment Fund Technological Innovations in Neuroscience Awards
Technological Innovations in Neuroscience Awards support scientists who work on novel and creative approaches to understanding brain function.
The program seeks to advance and enlarge the range of technologies available to the neurosciences. It does not support research based primarily on existing techniques.
The Endowment Fund is especially interested in how technology may be used or adapted to monitor, manipulate, analyze, or model brain function at any level, from the molecular to the entire organism. Technology may take any form, from biochemical tools to instruments to software and mathematical approaches. Because the program seeks to advance and enlarge the range of technologies available to the neurosciences, research based primarily on existing techniques will not be considered.
A goal of the Technological Innovations awards is to foster collaboration between the neurosciences and other disciplines; therefore, collaborative and cross-disciplinary applications are explicitly invited. Letters of Inquiry due: December 10, 2018; Full proposals due: April 22, 2019
https://www.mcknight.org/programs/the-mcknight-endowment-fund-for-neuroscience/technology-awards/

Patient-Centered Outcomes Research Institute Eugene Washington PCORi Engagement Awards
The Eugene Washington PCORI Engagement Award program, named in honor of the first chair of PCORI’s Board of Governors, aims to include patients, caregivers, clinicians, and other healthcare stakeholders in the research process. Our goal is to support projects that build communities prepared to participate in patient-centered outcomes research (PCOR) and comparative clinical effectiveness research (CER), as well as to serve as channels for disseminating study results. Building communities through engagement projects is central to our mission to fund useful CER that will help patients and those who care for them make better-informed healthcare decisions. We accept applications for three types of engagement projects: Dissemination Initiative, Capacity Building, and Conference Support. Letters of Inquiry due: February 1, 2019
https://www.pcori.org/funding-opportunities/research-support-funding-opportunities/eugene-washington-pcori-engagement

Rotary International CART Fund Alzheimer’s Research
The goal of the fund is to encourage exploratory and developmental AD research projects within the United States. This is accomplished by providing financial support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data but have the potential to substantially advance biomedical research. These projects should be distinct from those designed to increase knowledge in a well-established area unless they intend to extend previous discoveries toward new directions or applications.
Letters of Intent due: December 3, 2018.
http://www.cartfund.org/cart/applying-for-a-grant/

NSF Smart and Connected Health Program
The goal of the interagency Smart and Connected Health (SCH): Connecting Data, People and Systems program is to accelerate the development and integration of innovative computer and information science and engineering approaches to support the transformation of health and medicine. Approaches that partner technology-based solutions with biomedical and biobehavioral research are supported by multiple agencies of the federal government including the National Science Foundation (NSF) and the National Institutes of Health (NIH). The purpose of this program is to develop next-generation multidisciplinary science that encourages existing and new research communities to focus on breakthrough ideas in a variety of areas of value to health, such as networking, pervasive computing, advanced analytics, sensor integration, privacy and security, modeling of socio-behavioral and cognitive processes and system and process modeling. Effective solutions must satisfy a multitude of constraints arising from clinical/medical needs, barriers to change, heterogeneity of data, semantic mismatch and limitations of current cyberphysical systems and an aging population. Such solutions demand multidisciplinary teams ready to address issues ranging from fundamental science and engineering to medical and public
Proposals due: December 11, 2018
https://www.nsf.gov/pubs/2018/nsf18541/nsf18541.pdf

NIH Diet and Physical Activity Assessment Methodology
This Funding Opportunity Announcement (FOA) encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications submitted to this FOA may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods/modeling to improve assessment and/or to correct for measurement errors or biases; methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors.
R21 Clinical Trial Not Allowed, Cycle 1 due date: February 16, 2019: https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html
RO1 Research Grant Program, Cycle 1 due date: February 5, 2019: https://grants.nih.gov/grants/guide/pa-files/PA-18-856.html

NIH NCI Physical Activity and Weigh Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought. Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will include transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied.
R21 Clinical Trial Not Allowed, Cycle 1 due date: February 16, 2019: https://grants.nih.gov/grants/guide/pa-files/PAR-18-892.html
RO1 Research Grant Program, Cycle 1 due date: February 5, 2019: https://grants.nih.gov/grants/guide/pa-files/PAR-18-893.html

NIH NLM Research Grants in Biomedical Informatics and Data Science

The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. The scope of NLM’s interest in these research domains is broad, with emphasis on new methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, reusable approaches to discovery, curation, analysis, organization and management of health-related digital objects. Biomedical informatics and data science draw upon many fields, including mathematics, statistics, information science, computer science and engineering, and social/behavioral sciences. Application domains include health care delivery, basic biomedical research, clinical and translational research, precision medicine, public health, biosurveillance, health information management in disasters, and similar areas. NLM defines biomedical informatics as the science of optimal representation, organization, management, integration and presentation of information relevant to human health and biology. NIH defines data science as the interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are developed and used to extract knowledge and insights from increasingly large and/or complex sets of data.

RO1 Research Grant Program, Cycle 1 due date: February 5, 2019: https://grants.nih.gov/grants/guide/pa-files/PAR-18-896.html

NIH NLM Data Science Research: Personal Health Libraries for Consumers and Patients

The National Library of Medicine seeks applications for novel informatics and data science approaches that can help individuals gather, manage and use data and information about their personal health. A goal of this program is to advance research and application by patients and the research community through broadly sharing the results via publication, and through open source mechanisms for data or resource sharing.
Limited Submission Opportunity: Only one application per institution is allowed.
Letter of Intent due dates: December 18, 2018; June 28, 2019; December 17, 2020 (and more)
Application due dates: January 18, 2019; July 31, 2019; January 17, 2020 (and more)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-072.html

NIH NIDA/NIAAA Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence

The purpose of this FOA is two-fold: (1) to advance identification of male-female differences in drug and alcohol research outcomes, to uncover the mechanisms of those differences, and to conduct translational research on those differences, and (2) to advance research specific to women or highly relevant to women. Both preclinical and clinical studies are sought across all areas of drug and alcohol research.

RO1 Research Grant Program, Cycle 1 due date: February 5, 2019: https://grants.nih.gov/grants/guide/pa-files/PA-18-603.html
R21 Clinical Trial Optional, Cycle 1 due date: February 16, 2019: https://grants.nih.gov/grants/guide/pa-files/PA-18-602.html
RO3 Small Grant Program Clinical Trial Optional, Cycle 1 due date: February 16, 2019: https://grants.nih.gov/grants/guide/pa-files/PA-18-601.html

Questions? Contact the OSP Proposal Development Team